Astellas Pharma Inc 2021 AR2
The report highlights Astellas Pharma's performance and strategic progress for the fiscal year ended March 31, 2021. During this period, the company launched its Corporate Strategic Plan 2021 (CSP2021), which establishes key strategic goals including enabling better patient outcomes, advancing the Rx+ business, and deepening engagement in sustainability. Astellas achieved consolidated revenue of 1,249.5 billion yen, driven by sales of major products like XTANDI, XOSPATA, and PADCEV. In sustainability, the company made significant progress by reducing its Scope 1 and Scope 2 greenhouse gas emissions by 39% compared to the fiscal 2015 baseline. Additionally, Astellas continued its commitment to global health through collaborative research on tuberculosis, malaria, and neglected tropical diseases.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2021
Type: AR2
Pages: 205
Back to company
Astellas Pharma Inc
Annual Report
The report highlights Astellas Pharma's performance and strategic progress for the fiscal year ended March 31, 2021. During this period, the company launched its Corporate Strategic Plan 2021 (CSP2021), which establishes key strategic goals including enabling better patient outcomes, advancing the Rx+ business, and deepening engagement in sustainability. Astellas achieved consolidated revenue of 1,249.5 billion yen, driven by sales of major products like XTANDI, XOSPATA, and PADCEV. In sustainability, the company made significant progress by reducing its Scope 1 and Scope 2 greenhouse gas emissions by 39% compared to the fiscal 2015 baseline. Additionally, Astellas continued its commitment to global health through collaborative research on tuberculosis, malaria, and neglected tropical diseases.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Workplace Fatalities
Employees